This track focuses on the latest methodologies and tools in computational drug design, emphasizing innovative approaches and technologies. Participants will explore case studies that highlight successful applications in drug discovery.

This session will delve into various molecular docking techniques, including both rigid and flexible docking approaches. Discussions will center on the practical applications of these techniques in predicting ligand-receptor interactions.

This track will cover the principles and practices of structure-based drug design, focusing on the integration of structural biology and computational methods. Attendees will learn about the role of 3D structures in optimizing drug candidates.

This session will explore virtual screening methodologies and the development of pharmacophore models for identifying potential drug candidates. Participants will discuss the challenges and successes in applying these techniques in real-world scenarios.

This track will address the computational techniques used for predicting binding affinities and the evaluation of scoring functions in molecular docking. The focus will be on improving accuracy and reliability in drug design.

This session will highlight the role of molecular dynamics simulations in understanding protein-ligand interactions and drug stability. Participants will discuss how these simulations can inform lead optimization and drug design.

This track will focus on the computational approaches used for predicting ADMET properties and their significance in drug development. Discussions will include methodologies for assessing drug metabolism and toxicity.

This session will explore quantitative structure-activity relationship (QSAR) modeling techniques and their applications in predicting biological activity. Participants will discuss the integration of cheminformatics in enhancing QSAR models.

This track will cover the latest advancements in in silico screening methods for drug discovery. Emphasis will be placed on high-throughput screening and its integration with computational approaches.

This session will focus on the role of computational pharmacology in identifying and validating drug targets. Participants will explore case studies that demonstrate successful target identification using computational methods.

This track will discuss recent innovations in docking algorithms and their impact on the accuracy of molecular docking studies. Participants will evaluate the effectiveness of new algorithms in various drug design applications.